Related Experiment Video

Updated: May 27, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

The clinical effects of hospitalization in a low pollutant room on atopic dermatitis

Jung Hyun Lee1, Jihyun Kim, Sang Woon Lee

  • 1Department of Pediatrics, Gwangmyeong Sungae Hospital, Gwangmyeong 423-033, Korea.

Asia Pacific Allergy
|November 5, 2011
PubMed

Insights

Reducing indoor air pollutants significantly improved atopic dermatitis (AD) symptoms in children. Managing environmental factors, such as dust and volatile organic compounds (VOCs), is crucial for better AD outcomes.

Area of Science:

  • Environmental Health
  • Dermatology
  • Pediatrics

Background:

  • Environmental pollutants are recognized as key triggers for atopic dermatitis (AD).
  • Effective management of AD often requires addressing environmental triggers alongside conventional treatments.

Purpose of the Study:

  • To assess the clinical impact of a low indoor pollutant environment on managing atopic dermatitis (AD) in children.
  • To evaluate if reducing exposure to common indoor allergens and pollutants can improve AD severity.

Main Methods:

  • Fifty-one children with moderate-to-severe AD were admitted to a controlled low-pollutant environment for 3-4 days.
  • Disease severity was measured using Scoring of AD (SCORAD) indices before and after the stay.
  • Indoor air quality, including particulate matter (PM) and volatile organic compounds (TVOCs), was monitored and compared to home environments.

Main Results:

  • SCORAD indices significantly decreased from 42.0 to 29.8 (p < 0.001) after management in the low-pollutant room.
  • Patients' homes showed significantly higher levels of PM(2.5), PM(10), formaldehyde, TVOCs, carbon dioxide, bacteria, and molds compared to the controlled environment.
  • Readmission for 8 patients whose AD worsened at home led to a rapid SCORAD reduction, indicating environmental impact.

Conclusions:

  • Elevated indoor air pollutants likely exacerbate atopic dermatitis in susceptible children.
  • Environmental control strategies aimed at reducing indoor pollutant levels may be essential for optimizing AD management in certain patients.
Abstract

Keywords:
Air pollutionAtopic dermatitisChildhoodEnvironmentIndoor

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...